Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 APR 20 ... cancer indications. This work is in addition to a Phase I/II Study of Cordycepin plus Pentostatin in Patients with Refractory TdT-Positive Leukemia, sponsored by OncoVista that is ...
2009 NOV 2 ... (HCL) treatment is excellent, but evidence of cure with purine analogs cladribine and pentostatin, is lacking. Significant long-term immune suppression, particularly to CD4+ T-cells, and ...
2009 MAY 4 ... 001), typically had leukocytosis (P =. 014), and did not respond well to cladribine or pentostatin. We suggest categorizing CD103+ B-lymphoproliferative disorders into 2 groups," wrote ...
2009 NOV 2 ... described in 1958. The introduction of the two commonly used purine nucleoside analogs (pentostatin and cladribine, respectively) has independently changed the natural history of this rare ...
2009 MAR 2 ... protein expression prospectively as part of a phase 2 study evaluating the efficacy of pentostatin, cyclophosphamide, and rituximab in patients with untreated CLL. No significant ...
2009 JUL 20 ... this prognosis. We reviewed data retrospectively from 233 patients, treated with pentostatin (n = 188) or cladribine (n = 45), to investigate the current long-term outlook. Median ...
2009 NOV 2 ... till the early 1980s, when interferon-alfa and subsequently purine analogs (PAs) pentostatin or cladribine, or pentostatin were described to ...
2009 AUG 24 ... was found between similar drugs. Mitoxantrone (r=0.31), cyclophosphamide (r=0.35) and pentostatin (r=0.29) had low cross-resistance with fludarabine. Treatment resulted in increased ...
2009 NOV 2 ... with pancytopenia, splenomegaly, and recurrent infections. Although interferon alpha and pentostatin were initially found to be effective in this disease, cladribine has emerged as the ...
2009 MAY 11 ... payment resulting from the sale in a prior year of the worldwide rights for Nipent® (pentostatin for injection) to Mayne Pharma (acquired by Hospira, Inc. in February 2007). The gain on ...
2009 AUG 10 ... resulting from the sale in a prior year of the worldwide rights for Nipent® (pentostatin for injection) to Mayne Pharma (acquired by Hospira, Inc. in February 2007). ...
2008 DEC 22 ... Network, as well as a Mayo Clinic and MSKCC trials, evaluated the combination of pentostatin (P), cyclophosphamide (C), and rituximab (R) (PCR); results suggested similar efficacy ...
2008 AUG 18 ... According to a study from the United States, "Pentostatin, an adenosine deaminase (ADA) inhibitor, is a purine antimetabolite used for the ...
2008 AUG 11 ... All but one engrafted successfully, but with decreased OS and PFS. Two patients received pentostatin infusion prior to donor lymphocyte infusions in unsuccessful attempts at reversing ...
2008 AUG 18 ... Pharma (acquired by Hospira, Inc. in February 2007) related to the sale of Nipent(R) (pentostatin for injection) and the reversal of a residual product returns reserve for Nipent no ...
2008 NOV 17 ... a milestone payment in the amount of $1.8 million due to the achievement of Nipent(R) (pentostatin for injection) sales targets by Mayne Pharma (acquired by Hospira, Inc. in February ...
